Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Response to Treatment
100%
Polycystic Ovary Syndrome
100%
Confidence Interval
100%
Polymorphism
100%
Ovulatory Response
100%
STK11 Gene
100%
Body Mass Index
83%
Ovulation
83%
Metformin
83%
Adjusted Odds Ratio
66%
Free Androgen Index
66%
GC Genotype
50%
Liver
33%
Prospective Randomized Trial
16%
Academic Medical Centers
16%
Odds Ratio
16%
Single nucleotide Polymorphism
16%
Genotype
16%
Modifiable Factors
16%
Clomiphene
16%
Insulin Sensitizers
16%
Multicenter Randomized Clinical Trial
16%
Genetic Polymorphism
16%
Biochemical Parameters
16%
Genetic Parameters
16%
Low Body Mass Index
16%
STK11
16%
Liver Kinase B1 (LKB1)
16%
Predictive Genetic Testing
16%
Biometric Parameters
16%
Medicine and Dentistry
Body Mass Index
100%
Polycystic Ovary Syndrome
100%
Odds Ratio
83%
Glycon
83%
Ovulation
83%
Androgen
66%
Allele
33%
Randomized Clinical Trial
16%
Clomifene
16%
Conception
16%
Insulin Sensitizing Agent
16%
Biometry
16%
Single Nucleotide Polymorphism
16%
Cyclic AMP Dependent Protein Kinase
16%
Genetic Polymorphism
16%
Genetic Parameter
16%
Nursing and Health Professions
Body Mass
100%
Confidence Interval
100%
Ovary Polycystic Disease
100%
Odds Ratio
83%
Metformin
83%
Androgen
66%
University Hospital
16%
Clomifene
16%
Biometry
16%
Genetic Parameters
16%
Insulin Sensitizing Agent
16%
Cyclic AMP Dependent Protein Kinase
16%
Biochemistry, Genetics and Molecular Biology
Body Mass
100%
STK11
100%
Ovulation
83%
Genotyping
66%
Free Androgen Index
66%
Allele
33%
Single-Nucleotide Polymorphism
16%
Sensitization
16%
Protein Kinase A
16%
Genetic Polymorphism
16%
Conception
16%
Genetic Parameters
16%
Randomized Clinical Trial
16%
Neuroscience
Body Mass Index
100%
STK11
100%
Metformin
83%
Free Androgen Index
66%
Protein Kinase A
16%
Single-Nucleotide Polymorphism
16%
Genetic Polymorphism
16%
Clomifene
16%